Vaccines currently routinely recommended to the general population in the U.S.* have not been shown to cause complex regional pain syndrome (CRPS).
The 2012 report by the Institute of Medicine (IOM), now called the National Academy of Medicine (NAM), found no relevant studies of quality in the literature assessing CRPS and vaccination1. A combined analysis of seven phase III clinical trials of 9-valent HPV vaccine published since this report found no association between the vaccine and CRPS.2 Two Danish studies with nationwide coverage3,4 and a US case-cohort analysis5 also found no association between HPV vaccine and CRPS.
Previous controlled studies have shown an association between pain and injection of norepinephrine and phenylephrine.6,7 About half of patients with CRPS have documented trauma to the affected area prior to injection.1
The 2012 IOM report described one case of CRPS after hepatitis B vaccination showing a reoccurrence of symptoms after vaccine re-challenge.8 However, the rest of the publications reviewed provided little evidence beyond a temporal association.1
* These conclusions do not necessarily consider vaccines recommended only for special populations in the United States such as Yellow Fever vaccine (international travelers) or Smallpox vaccine (military personnel), or vaccines no longer recommended to the public such as the Janssen (J&J) COVID-19 vaccine.
1. Institute of Medicine. In: Stratton K, Ford A, Rusch E, Clayton EW, eds. Adverse Effects of Vaccines: Evidence and Causality. Washington (DC): National Academies Press (US); 2012.
2. Moreira ED, Jr., Block SL, Ferris D, Giuliano AR, Iversen OE, Joura EA, Kosalaraksa P, Schilling A, Van Damme P, Bornstein J, Bosch FX, Pils S, Cuzick J, Garland SM, Huh W, Kjaer SK, Qi H, Hyatt D, Martin J, Moeller E, Ritter M, Baudin M, Luxembourg A. Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials. Pediatrics 2016; 138(2).
3. Hviid A, Thorsen NM, Valentiner-Branth P, Frisch M, Mølbak K. Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis. BMJ (Clinical research ed) 2020; 370: m2930.
4. Thomsen RW, Öztürk B, Pedersen L, Nicolaisen SK, Petersen I, Olsen J, Sørensen HT. Hospital Records of Pain, Fatigue, or Circulatory Symptoms in Girls Exposed to Human Papillomavirus Vaccination: Cohort, Self-Controlled Case Series, and Population Time Trend Studies. American journal of epidemiology 2020; 189(4): 277-85.
5. Vielot NA, Becker-Dreps S. Hazard of complex regional pain syndrome following human papillomavirus vaccination among adolescent girls in the United States: a case-cohort analysis of insurance claims data. Expert opinion on drug safety 2020; 19(1): 107-12.
6. Ali Z, Raja SN, Wesselmann U, Fuchs PN, Meyer RA, Campbell JN. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain 2000; 88(2): 161-8.
7. Mailis-Gagnon A, Bennett GJ. Abnormal contralateral pain responses from an intradermal injection of phenylephrine in a subset of patients with complex regional pain syndrome (CRPS). Pain 2004; 111(3): 378-84.
8. Jastaniah WA, Dobson S, Lugsdin JG, Petty RE. Complex regional pain syndrome after hepatitis B vaccine. The Journal of pediatrics 2003; 143(6): 802-4.
Institute for Vaccine Safety
Johns Hopkins Bloomberg School of Public Health
615 N Wolfe Street
Baltimore, MD 21205
USA
info@vaccinesafety.edu
All rights reserved.
© 2024 Institute for Vaccine Safety
This website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Member since 2006